Screener
ELIL vs CURE
Direxion Daily LLY Bull 2X Shares vs Direxion Daily Healthcare Bull 3X Shares
Key differences
- CURE costs 0.13% less per year.
- CURE is significantly larger than ELIL — larger funds tend to be more liquid and less likely to close.
- CURE has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| ELIL | CURE | |
|---|---|---|
| Annual cost (TER) | 1.07% | 0.94% |
| Fund size (AUM) | $18M | $138M |
| Since | 2025 | 2011 |
| Dividend yield | 16.07% | 1.33% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | leveraged | leveraged |
| CAGR 1Y | +71.5% | +31.7% |
| CAGR 3Y | N/A | +0.8% |
| CAGR 5Y | N/A | +0.7% |
| Sharpe 3Y | N/A | 0.14 |
| Volatility 1Y | 74.88% | 42.92% |
| Max drawdown | -56.03% | -69.19% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to ELIL and CURE
Explore further